Anixa Biosciences is trading at $2.93, up 5.53% in after-hours trading; no confirmed company announcement explaining the move was found.
- A report says CEO Amit Kumar bought 8,000 shares at $2.72 on October 22, but does not link the purchase to the price change.
- The regular-session close was $2.78, up 2.58%.
- The broader market was sharply lower, so market-wide sentiment does not clearly explain the rise.